Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002

Gunnar H Gislason, Steen Abildstrøm, Søren Rasmussen, Jeppe N Rasmussen, Pernille Buch, Ida Gustafsson, Jens Friberg, Niels Gadsbøll, Lars Køber, Steen Stender, Mette Madsen, Christian Torp-Pedersen

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Resumé

Udgivelsesdato: 2005-Apr
OriginalsprogEngelsk
TidsskriftScandinavian Cardiovascular Journal
Vol/bind39
Udgave nummer1-2
Sider (fra-til)42-9
Antal sider7
ISSN1401-7431
StatusUdgivet - 1. apr. 2005
Udgivet eksterntJa

Fingeraftryk

Denmark
Prescriptions
Sodium Potassium Chloride Symporter Inhibitors
Hypoglycemic Agents
Registries
Pharmacies

Citer dette

Gislason, G. H., Abildstrøm, S., Rasmussen, S., Rasmussen, J. N., Buch, P., Gustafsson, I., ... Torp-Pedersen, C. (2005). Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002. Scandinavian Cardiovascular Journal, 39(1-2), 42-9.
Gislason, Gunnar H ; Abildstrøm, Steen ; Rasmussen, Søren ; Rasmussen, Jeppe N ; Buch, Pernille ; Gustafsson, Ida ; Friberg, Jens ; Gadsbøll, Niels ; Køber, Lars ; Stender, Steen ; Madsen, Mette ; Torp-Pedersen, Christian. / Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002. I: Scandinavian Cardiovascular Journal. 2005 ; Bind 39, Nr. 1-2. s. 42-9.
@article{8a8153b081a211de9c46000ea68e967b,
title = "Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002",
abstract = "OBJECTIVES: To study the use of beta-blockers and angiotensin-converting enzyme (ACE) inhibitors after acute myocardial infarction (AMI) in Denmark from 1995 to 2002. DESIGN: Information about patients with first AMI aged > or = 30 years and the dispensing of beta-blockers and ACE inhibitors from pharmacies within 30 d from discharge was obtained from the National Patient Registry and the Danish Registry of Medicinal Product Statistics. RESULTS: Beta-blocker use increased from 38.1{\%} of patients in 1995 to 67.9{\%} in 2002 (OR = 3.85, CI: 3.58-4.13). Women, elderly patients and patients taking loop-diuretics and antidiabetic drugs received beta-blockers less frequently, but patients taking loop-diuretics or antidiabetic drugs had the greatest increase. ACE inhibitor use increased from 24.5 to 35.5{\%} (OR = 1.86, CI: 1.72-2.01). Women, patients aged < 60 years or > or = 80 years and patients not taking loop-diuretics received ACE inhibitors less frequently, but patients not taking loop-diuretics had the greatest increase. CONCLUSIONS: Beta-blocker use increased markedly post-AMI from 1995 to 2002, whereas ACE inhibitor use increased modestly. The results suggested undertreatment of women, elderly patients and people with diabetes.",
author = "Gislason, {Gunnar H} and Steen Abildstr{\o}m and S{\o}ren Rasmussen and Rasmussen, {Jeppe N} and Pernille Buch and Ida Gustafsson and Jens Friberg and Niels Gadsb{\o}ll and Lars K{\o}ber and Steen Stender and Mette Madsen and Christian Torp-Pedersen",
year = "2005",
month = "4",
day = "1",
language = "English",
volume = "39",
pages = "42--9",
journal = "Scandinavian Cardiovascular Journal",
issn = "1401-7431",
publisher = "Taylor & Francis",
number = "1-2",

}

Gislason, GH, Abildstrøm, S, Rasmussen, S, Rasmussen, JN, Buch, P, Gustafsson, I, Friberg, J, Gadsbøll, N, Køber, L, Stender, S, Madsen, M & Torp-Pedersen, C 2005, 'Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002', Scandinavian Cardiovascular Journal, bind 39, nr. 1-2, s. 42-9.

Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002. / Gislason, Gunnar H; Abildstrøm, Steen; Rasmussen, Søren; Rasmussen, Jeppe N; Buch, Pernille; Gustafsson, Ida; Friberg, Jens; Gadsbøll, Niels; Køber, Lars; Stender, Steen; Madsen, Mette; Torp-Pedersen, Christian.

I: Scandinavian Cardiovascular Journal, Bind 39, Nr. 1-2, 01.04.2005, s. 42-9.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

TY - JOUR

T1 - Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002

AU - Gislason, Gunnar H

AU - Abildstrøm, Steen

AU - Rasmussen, Søren

AU - Rasmussen, Jeppe N

AU - Buch, Pernille

AU - Gustafsson, Ida

AU - Friberg, Jens

AU - Gadsbøll, Niels

AU - Køber, Lars

AU - Stender, Steen

AU - Madsen, Mette

AU - Torp-Pedersen, Christian

PY - 2005/4/1

Y1 - 2005/4/1

N2 - OBJECTIVES: To study the use of beta-blockers and angiotensin-converting enzyme (ACE) inhibitors after acute myocardial infarction (AMI) in Denmark from 1995 to 2002. DESIGN: Information about patients with first AMI aged > or = 30 years and the dispensing of beta-blockers and ACE inhibitors from pharmacies within 30 d from discharge was obtained from the National Patient Registry and the Danish Registry of Medicinal Product Statistics. RESULTS: Beta-blocker use increased from 38.1% of patients in 1995 to 67.9% in 2002 (OR = 3.85, CI: 3.58-4.13). Women, elderly patients and patients taking loop-diuretics and antidiabetic drugs received beta-blockers less frequently, but patients taking loop-diuretics or antidiabetic drugs had the greatest increase. ACE inhibitor use increased from 24.5 to 35.5% (OR = 1.86, CI: 1.72-2.01). Women, patients aged < 60 years or > or = 80 years and patients not taking loop-diuretics received ACE inhibitors less frequently, but patients not taking loop-diuretics had the greatest increase. CONCLUSIONS: Beta-blocker use increased markedly post-AMI from 1995 to 2002, whereas ACE inhibitor use increased modestly. The results suggested undertreatment of women, elderly patients and people with diabetes.

AB - OBJECTIVES: To study the use of beta-blockers and angiotensin-converting enzyme (ACE) inhibitors after acute myocardial infarction (AMI) in Denmark from 1995 to 2002. DESIGN: Information about patients with first AMI aged > or = 30 years and the dispensing of beta-blockers and ACE inhibitors from pharmacies within 30 d from discharge was obtained from the National Patient Registry and the Danish Registry of Medicinal Product Statistics. RESULTS: Beta-blocker use increased from 38.1% of patients in 1995 to 67.9% in 2002 (OR = 3.85, CI: 3.58-4.13). Women, elderly patients and patients taking loop-diuretics and antidiabetic drugs received beta-blockers less frequently, but patients taking loop-diuretics or antidiabetic drugs had the greatest increase. ACE inhibitor use increased from 24.5 to 35.5% (OR = 1.86, CI: 1.72-2.01). Women, patients aged < 60 years or > or = 80 years and patients not taking loop-diuretics received ACE inhibitors less frequently, but patients not taking loop-diuretics had the greatest increase. CONCLUSIONS: Beta-blocker use increased markedly post-AMI from 1995 to 2002, whereas ACE inhibitor use increased modestly. The results suggested undertreatment of women, elderly patients and people with diabetes.

M3 - Journal article

C2 - 16097413

VL - 39

SP - 42

EP - 49

JO - Scandinavian Cardiovascular Journal

JF - Scandinavian Cardiovascular Journal

SN - 1401-7431

IS - 1-2

ER -